The Continual Search for Biomarkers - Cancer, Cardiovascular, Immunology, Infectious Diseases and Neurological Diseases

Biomarkers are a highly dynamic space within life science characterized by individual progression through discovery; validation; initial standardized applications in preclinical studies and clinical trials; and incorporation into clinically approved in vitro diagnostic (IVD) assays. In addition to vertical movement, individual biomarkers can be viewed in a horizontal manner across the spectrum of applicable diseases. This spectrum of biomarker usage is encompassed in Kalorama Information’s The G...


Propelled by NIPT, China Moves to the Fore in NGS Assays

Propelled by NIPT, China Moves to the Fore in NGS Assays

China is playing an increasingly significant role not only in the IVD industry, but global clinical markets. Kalorama Information offers comprehensive subject reports that variously treat the Chinese IVD , global cancer diagnostics , prenatal testing , circulating tumor cells (CTCs) , and next-generation sequencing (NGS) markets.

The stakes are high for clinical next-generation sequencing (NGS) platform vendors in the Chinese market. In 2014, the Chinese Food & Drug Administration (CFDA; SFDA)...


Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Modern medicine’s more than century-long fight to treat cancer and eradicate tumors will likely benefit from a more diverse and effective arsenal in the coming years. Through a variety of routes and techniques, gene therapies are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor. Gene therapies have already found clinical successes in the treatment of several non-cancer diseases, though the oncolytic or immune system-assisted...